(Received for publication, May 1, 1997, and in revised form, June 30, 1997)
From the Institute of Laboratory Medicine, Department
of Clinical Chemistry and Transfusion Medicine, Sahlgrenska University
Hospital, S-413 45 Göteborg, Sweden, § INSERM U.178,
Villejuif 94807, France, and the ¶ New South Wales Red Cross Blood
Transfusion Service, Sydney 2000, Australia
The Lewis
(1,3/1,4)-fucosyltransferase, Fuc-TIII, encoded by the
FUT3 gene is responsible for the final synthesis of
Lea and Leb antigens. Various point mutations
have been described explaining the Lewis negative phenotype,
Le(a
b
), on erythrocytes and secretions. Two of these, T202C and
C314T originally described in a Swedish population, have not been found
as single isolated point mutations so far. To define the relative
contribution of each of these two mutations to the Lewis negative
phenotype, we cloned and made chimeric FUT3 constructs
separating the T202C mutation responsible for the amino acid change
Trp68
Arg, from the C314T mutation leading to the
Thr105
Met shift. COS-7 cells were transfected and the
expression of Fuc-TIII enzyme activity and the presence of Lewis
antigens were determined. There was no decrease in enzyme activity nor of immunofluorescence staining on cells transfected with the construct containing the isolated C314T mutation compared with cells transfected with a wild type FUT3 allele control. No enzyme activity
nor immunoreactivity for Lewis antigens was detected in
FUT3 constructs containing both mutations in combination.
The T202C mutation alone decreased the enzyme activity to less than 1%
of the activity of the wild type FUT3 allele. These results
demonstrate, that the Trp68
Arg substitution in human
Fuc-TIII is the capital amino acid change responsible for the
appearance of the Le(a
b
) phenotype on human erythrocytes in
individuals homozygous for both the T202C and C314T mutations.
The Lewis histo-blood group system comprises different complex carbohydrate structures, which participate in different biological processes such as embryogenesis, tissue differentiation, tumor metastasis, inflammation, and bacterial adhesion (1). Lea1 and Leb (2, 3) are the major Lewis antigens found on human erythrocytes. These fucosylated glycosphingolipids are synthesized by exocrine epithelial cells (4) and are secondarily passively adsorbed onto erythrocytes in the peripheral circulation giving these blood cells their Lewis phenotype (5).
It was shown as early as the 1950's, that the Lewis phenotype of erythrocytes is influenced by the ABH secretor status of the individual (6), and the erythrocyte phenotype is the result of the epistatic interaction of the Lewis (Le-le) and the salivary ABH secretor (Se-se) loci (7). Fucosyltransferases (Fuc-Ts) encoded by genes at these loci compete and interact with each other and with other glycosyltransferases to determine the individual's final Lewis and secretor phenotypes.
Since 1990, seven human fucosyltransferase genes (FUT1-7)
have been cloned, sequenced, and characterized according to acceptor specificities (8-18). The human (1,2)-Fuc-T gene family comprises FUT1 encoding for the H enzyme and FUT2 encoding
for the human secretor
(1,2)-fucosyltransferase (9).
FUT3-7 encode for
(1,3)-Fuc-Ts. Two of these human
enzymes, Fuc-TIII and Fuc-TV encoded by the FUT3 and
FUT5 genes, respectively (10, 14), also express
(1,4)-fucosyltransferase activities (15, 19, 20).
Five main missense mutations have been identified in FUT3.
Together they explain the majority of Lewis negative phenotypes on
erythrocytes and in secretions. In Indonesians (21) the T1067A mutation, and in Japanese (22, 23) the T1067A and G508A mutations have
been identified. These mutations were also found in studies on Swedish
individuals (24). In the latter population, two additional FUT3 mutations T202C and C314T (24, 25) were identified, and they constitute the Lewis negative allele
le202-314, typically occurring in Swedish
Le(ab
) individuals. These latter mutations have so far not been
found separately except for the rare
le59-202-1067 allele (24). The T59G missense
mutation has been described in studies on Indonesians (21), Japanese
(22, 23), and in Sweden (24). The corresponding amino acid is located
in the transmembrane region of Fuc-TIII, and may modify the anchoring of the enzyme on the Golgi membrane (21), but is not by itself able to
inactivate the enzyme activity.
The aim of this study was to examine which of the FUT3
mutations, T202C or C314T, was responsible for inactivating the
Fuc-TIII enzyme. By making chimeric FUT3 constructs and
transfecting COS-7 cells, it was possible to show that the Fuc-TIII
enzyme with the isolated amino acid substitution Trp68 Arg, was only able to synthesize less than 1% of the fucosylated structures made by the FUT3 wild type under the same
conditions. This demonstrates that the T202C alteration is the major
inactivating point mutation of the le202-314
allele.
Two individuals (numbers 3 and 5),
previously characterized for Lewis erythrocyte phenotype and
FUT3 genotype (24, 25) were chosen for this study.
Individual number 3 was phenotyped on erythrocytes as Le(ab
) and
genotyped as homozygously mutated for the T202C and C314T
FUT3 mutations. Number 5 was phenotyped as Le(a
b+) and had
the wild type sequence of FUT3 (10). DNA from one Le(a
b
)
individual designated 529 (26), carrying the FUT3 inactive
allele le1067, was chosen as a negative
control.
PCR was used to amplify the coding region, and
immediately adjacent 5- and 3
-flanking regions of the FUT3
gene of individuals numbers 3, 5, and 529. Genomic DNA (0.25-0.5 µg)
was amplified in a PTC-100-96V thermal cycler (MJ Research, Inc.,
Watertown, MA), using PCR mixtures and reagents as described in Ref. 24 with 25 pmol of each primer. The PCR program included hot start at
85 °C for 10 min, followed by 33 cycles with 15 s at 95 °C, 15 s at 60 °C, and 3 min at 68 °C. The last extension step
was elongated 10 min at 68 °C. The sense primer (EL-29 s)
5
-cccgaattcaagcttCTCTCCAGATACTCTGACCC-3
anneals to
nucleotides
1 to
20 (10) and contains additional nucleotides
(lowercase) at its 5
end, including an EcoRI and a
HindIII (underlined) restriction site. The antisense primer (EL-25as) 5
-aaagaattcgcggccGCCACAAAGGACTCCA-3
is
complementary to nucleotides 1159-1144 (10), and the additional
nucleotides (lowercase) at its 5
end include an EcoRI and a
NotI (underlined) restriction site. The 1209-bp PCR products
were purified on NuSieve-agarose gels (FMC BioProducts, Rockland, ME)
according to Ref. 27 and ligated into the pCRII TA-cloning vector
(Invitrogen Corp., San Diego, CA) or the pTAg TA-cloning vector (R&D
Systems, Abingdon, United Kingdom). Positive clones were selected by
blue-white screening. Sequencing of TA clones was done as described
(24, 25). One clone without PCR induced errors of each individual was
chosen for subcloning of its FUT3 insert into the mammalian
expression vector pcDNA1/Amp (Invitrogen).
For subcloning of FUT3 inserts, HindIII (New England Biolabs, Beverly, MA) and NotI (Boehringer Mannheim Scandinavia AB, Bromma, Sweden) were used for double digests of the three selected TA clones and pcDNA1/Amp. The latter was also treated with alkaline phosphatase (Boehringer Mannheim). The FUT3 inserts and pcDNA1/Amp were purified on SeaPlaque-agarose gels (FMC BioProducts) and the purified FUT3 fragments were subcloned into the purified restricted (HindIII-NotI) expression vector using T4 DNA ligase (Boehringer Mannheim).
The chimeric FUT3 vector constructs were made by restriction cleavages of the two selected TA-clones of individuals numbers 3 and 5, respectively. Double digest (HindIII-NotI) created an 1188-bp fragment, which was purified on NuSieve-agarose gel and subsequently cleaved by BsaOI (Promega, Madison, WI). BsaOI cleaved only at nucleotide position 288 in the coding region of FUT3 and created two different fragments, 313 and 875 bp, respectively. These fragments were purified on NuSieve-agarose gels and the 313-bp fragment of individual number 3 was ligated to the 875-bp fragment of individual number 5 together with restricted (HindIII-NotI) pcDNA1/Amp. This created a pcDNA1/Amp-FUT3 construct with the isolated T202C mutation. To make the construct with the isolated C314T mutation, the longer fragment of individual number 3 and the shorter fragment of individual number 5 were ligated into the restricted expression vector.
E. coli Strains DH5FUT3 constructs and cultured in large scale. All different plasmid constructs were prepared and purified by two consecutive CsCl/ethidium bromide equilibrium ultracentrifugations (28) and sequenced completely once more (24, 25), using AmpliTaq DNA polymerase FS kit (Perkin-Elmer), to verify the presence of a full-length FUT3 insert in the right direction to the cytomegalovirus promoter and the expected point mutations of each construct.
TransfectionCOS-7 cells were cultured in Dulbecco's modified Eagle's medium supplemented with 20% heat-inactivated fetal calf serum and transfected with 10 µg of expression vector constructs using the DEAE-dextran method (29). The cells were selected for transfection with pcDNA1 (CLONTECH Laboratories, Inc.) without insert as a negative control and with five different pcDNA1/Amp-FUT3 constructs. These different constructs were the FUT3 wild type, the T202C and C314T mutations in combination, the isolated T202C mutation, the isolated C314T mutation, and finally the T1067A isolated mutation. One µg of expression vector containing the coding region of the bacterial chloramphenicol acetyltransferase (pcDM8-CAT) (30), was simultaneously transfected to allow for normalization of transfection efficiency. Transfected cells were harvested after a 48-h growth period.
Immunofluorescent Expression of Lewis Antigens on the Surface of Transfected COS-7 CellsThe transfected cells were trypsinized, washed, and labeled with different antibodies. Mouse monoclonal anti-Lex antibodies used were: 82H5 (Chembiomed, Alberta Research Council, Edmonton, Canada) and SSEA-1 (Valbiotech, Paris, France). Mouse monoclonal anti-sialyl-Lex used was KM93 (Valbiotech). Mouse monoclonal anti-B 026 and anti-Lea 069 (31) were obtained from the Second International Workshop on Monoclonal Antibodies Against Human Red Blood Cells (32). The mouse monoclonal anti-Lea 7LE (33) and the mouse monoclonal anti-sialyl-Lea 19.9 were from J. Bara (INSERM U55, St. Antoine Hospital, Paris, France).
After 30 min incubation with the first antibody, the cells were washed with phosphate-buffered saline and incubated another 30 min with affinity purified fluorescein isothiocyanate-conjugated sheep anti-mouse immunoglobulins as second antibodies (Pasteur Diagnostics, Marnes la Coquette, France). After labeling with the second antibody the cells were washed with phosphate-buffered saline and fixed with 10 µl of 4% phosphate-buffered saline-paraformaldehyde. Five µl of Mowiol 4:80 (Hoechst, Frankfurt am Main, Germany) were added before mounting under coverslides. The cells were observed and counted under a Leitz SM-LUX epifluorescence microscope (34, 35).
Fucosyltransferase AssayEnzyme activity was measured at
37 °C in 30-µg aliquots of the 1% Triton X-100 protein extracts
of COS-7 cells transfected with the pcDNA1 vector alone and
containing the different FUT3 constructs with the
T202C, C314T, and T1067A mutations. Fucose incorporation was measured
with the donor GDP-[14C]fucose (Amersham, 300 mCi/mmol)
and acceptor substrates H type 1 Fuc1,2Gal
1,3GlcNAc
1-O-(CH2)8COOCH3
and
Gal
1,3GlcNAc
1-O-(CH2)8COOCH3 (Chembiomed) by the Sep-Pak C18 product isolation procedure
(36, 37). Enzyme kinetics were determined at initial velocity (15 min
for the 314 mutated and the wild type FUT3 constructs and 14 h for the 202 mutated construct) for GDP-fucose and H type 1.
One clone of each pcDNA1/Amp-FUT3 construct used for transfection studies was sequenced. This confirmed that all constructs contained the complete coding region of the human FUT3 gene in the right direction to the cytomegalovirus promoter. The pcDNA1/Amp-FUT3(wt) construct was verified to have the FUT3 wild type sequence. The pcDNA1/Amp-FUT3(1067) and the pcDNA1/Amp-FUT3(202-314) constructs contained the mutations T1067A, and T202C and C314T, respectively. The chimeric constructs, pcDNA1/Amp-FUT3(202) and pcDNA1/AmpFUT3(314), contained each of the isolated mutations on a FUT3 wild type background, and also the correct sequence over the BsaOI restriction site, respectively.
Expression of pcDNA1/Amp-FUT3 Wild, Mutated, and Chimeric ConstructsImmunofluorescence results are summarized in Table I. Carbohydrate epitopes Lex, sialyl-Lex, Lea, and sialyl-Lea were all found on COS-7 cells transiently transfected with the pcDNA1/Amp-FUT3(314) construct. The pcDNA1 /Amp-FUT3(wt) construct was used as a positive control and the percentage of positive cells and the intensity of the fluorescence were of the same order of magnitude for both these constructs. In contrast, COS-7 cells transfected with vectors containing the T202C and C314T mutations in combination, pcDNA1/Amp-FUT3(202-314), or the T1067A alone, pcDNA1/Amp-FUT3(1067), did not show any expression of Lex, sialyl-Lex, Lea, or sialyl-Lea epitopes. Transfection with the 202 mutated construct, pcDNA1/amp-FUT3(202), resulted in a weak production of Lewis epitopes as compared with the 314 mutated and the FUT3 wild type constructs (Table I). These results indicated that the isolated T202C mutation was the major alteration responsible for the appearance of the Lewis negative phenotype on COS-7 cells transfected with the pcDNA1/Amp-FUT3(202-314) allele.
|
Enzyme activity after 1 h
incubation was measured with two different acceptors (Table
II). These acceptors were: (i) the
disaccharide precursor of type 1, which can incorporate fucose in
1,2-linkage on the terminal Gal and in
1,4-linkage on the
internal GlcNAc and (ii) the unambiguous trisaccharide H type 1, which
can only incorporate fucose in the
1,4 position on the internal
GlcNAc. This last trisaccharide was the better acceptor and it was more than twice as efficient as the disaccharide, confirming previous results (35, 36). The 314 mutated construct gave results similar to the
wild type FUT3 construct and no enzyme activity could be detected with either of the 1067 mutated or the double mutated 202-314
constructs, in good accordance with the fluorescence results (Table I).
However, with both acceptors the single 202 mutated construct gave less
than 1% of the activity observed with the wild type FUT3
construct (Table II). Since these results suggested a much lower
relative activity, for the 202 mutated construct, than the fluorescence
results (Table I), the enzyme activity was measured again as a function
of incubation time for the better acceptor, H type 1 (Table
III). This experiment showed that both the wild type FUT3 and the 314 mutated constructs reached
maximum incorporation after 6 h, while the 202 mutated construct
kept linear kinetics for a longer time and reached just above 10% of the maximum wild type incorporation after 21 h. A very weak
activity could also be detected for the 202-314 mutated construct, but it did not reach more than 0.5% of the maximum incorporation of the
wild type FUT3.
|
|
The enzyme kinetics with GDP-fucose and H type 1 showed similar Km values for the homogenates of cells transfected with the FUT3 wild type, with the 314 or with the 202 mutated constructs. However, a dramatic decrease (>100-fold) of Vmax was observed for the 202 mutated construct as compared with the other two constructs (Table IV).
|
The importance of the le202-314 allele
either in homozygous or in heterozygous state in conjunction with an
additional le allele, for the appearance of the Le(ab
)
phenotype on erythrocytes was originally demonstrated in a Swedish
population (24). This has also recently been observed in studies on
French individuals from the Reunion
island.2 The significance of
this allele was recently confirmed in expression and enzymatic studies
on transfected COS-7 cells (38), where some of our own unpublished
FUT3-primers were used for PCR amplifications. It was
hypothesized in this latter study that the C314T mutation of the
le202-314 allele might be the more important of
the two mutations for introducing the Lewis negative phenotype on
erythrocytes.
In an earlier study the acceptor specificities of Fuc-TIII, Fuc-TV, and Fuc-TVI were shown to be dependent on the variation of 11 amino acid residues in a region corresponding to the Fuc-TIII amino acids 103-153 (39). The Fuc-TIII amino acid Thr105 is indeed located in this region but it was not identified as one of these 11 amino acids affecting the enzyme substrate specificity. A more recent study using truncated forms of Fuc-TIII and Fuc-TV demonstrated that only constructs containing amino acids 62-361 of Fuc-TIII and 76-374 of Fuc-TV were active, whereas shorter forms of the enzymes were inactive (40). This supports the results of the present study that amino acid Trp68 of Fuc-TIII (and the corresponding Trp81 of Fuc-TV) are indeed amino acids necessary for enzymatic activity of these fucosyltransferases.
We have in parallel cloned and sequenced the corresponding FUT3, FUT5, and FUT6 genes of the chimpanzee3 and the bovine futb gene (35), and aligned these sequences with the human FUT3, FUT5, and FUT6 sequences. The tryptophan residue at position 68, which is affected by the T202C mutation of human Fuc-TIII, is conserved in the corresponding positions of the three human, three chimpanzee, and bovine Fuc-Ts. In contrast, the threonine residue at position 105, affected by the C314T mutation of human Fuc-TIII, is only found in the chimpanzee Fuc-TIII, but not in the human or chimpanzee Fuc-TVs or Fuc-TVIs, nor in the bovine Futb enzyme where an alanine residue was identified at the corresponding positions.
By using chimeric FUT3 constructs, separating the T202C
mutation from the C314T mutation, we have now shown that the former mutation (T202C) is the essential one for the Le(ab
) phenotype on
transfected COS-7 cells and most probably also on human erythrocytes. The T
C mutation at nucleotide 202 induces a major amino acid change, tryptophan to arginine at amino acid position 68. This Trp68 position of the Fuc-TIII enzyme is in a highly
hydrophobic area (10, 39-41) and a shift to a charged hydrophilic
amino acid such as Arg in this position may induce changes in the
folding of the protein which might be responsible for the dramatic
decrease of the Vmax of the mutated enzyme. The
relative significance of the two substitutions at amino acids 68 and
105 versus the wild type enzyme are illustrated in the Hopp
and Woods hydropathicity plots in Fig. 1
(42). From these plots it is obvious that the Trp68
Arg
has a major effect while the Thr105
Met has only a
minor effect on this character of the Fuc-TIII enzyme. However, it is
also worth noticing that the naturally occurring allele,
le202-314, in our extended enzymatic studies
encodes for a protein that was about 20 times less active than that
encoded for by the 202 mutated construct and more than 200 times less
active than the wild type enzyme. Thus, there seems to be a synergistic
negative effect on the protein activity of these two mutations which
contrasts to the single point mutation at nucleotide 1067 resulting in
a protein without any measurable enzyme activity. The molecular explanation for these results will have to await experimental data on
the three-dimensional structure of the human Lewis Fuc-TIII enzyme and
its interaction with the Golgi membrane, neighboring proteins,
GDP-fucose, and the acceptor substrates.
FUT1 to FUT7 are the Genome Data Base (GDB) registered names of the cloned human fucosyltransferase genes, accessible in the EMBL/GenBank data libraries under accession numbers: M35531, U17894, X53578, M58596/M58597/S65161/M65030, M81485, L01698/M98825, and X78031/U08112/U11282.